Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
NEWS Manitoba Palliative Care Nurses Association April 2010 PRESIDENT’ MESSAGE Greetings! February and the Olympics have come and gone. We have grateful hearts. March has arrived and winter makes a last hurrah while spring whispers stirrings of hope and rebirth. Our 3rd annual MPCNA Mardi Gras self-care night on Feb 16th at the CRNM building was a resounding success once again. The Wellington College Massage students, Susan French, Rebecca Swanson and Flavio Carvalho, brought wonderful relief to stressed nurses with their healing touch. Our dry hard working hands were pampered and left feeling like silk by the Mary Kay representatives Christine Neale, and Sharyn Evans. The foot care nurses, Marge Tokar, Lise Forest, and Marilyn Chambers gave our weary feet an exquisite and restorative "soul to sole" experience. A self-care gift was generously donated by the College of LPN's of Manitoba. The executive members of the MPCNA, Donna Grassie, Rachel Mierke, Florence Misurka and Amanda Hopps are extraordinary women who do so much to promote excellence in Palliative care. A heartfelt appreciation goes out to them and all those who made this evening so much fun. Congratulations to all the participants for deeming yourselves worthy of self-care. "To love ones self is the beginning of a life long romance." Oscar Wilde. The MPCNA is very excited to announce that Dr. David Kuhl will be coming for a full day workshop this May 8th, a Saturday at the Deer Lodge Life and Learning Center. Dr. Kuhl's recent work has focused on understanding the physical, emotional and spiritual impact on caregivers as they care for patients/residents who are dying, suffering or experiencing a crisis. Working with the dying is stressful and powerful. Pain which goes untransformed will be transmitted. In doing our own inner work we can move towards weaving our experiences into a tapestry of beauty with a renewed sense of meaning and purpose. Take the time to embrace yourself with loving care, celebrate the Mardi Gras along the way, and remember "Caring is Kuhl". Please consider coming to our workshop. Take Care Debbie Springet Frymire, President, MPCNA UPCOMING EVENTS Manitoba Palliative Care Nurses Association SPRING WORKSHOP May 8, 2010. 0830-1600 hrs. Deer Lodge Life and Learning Centre, 2nd floor, 2109 Portage Ave. Winnipeg, MB. Sustaining Health Care Providers in the Work Place “CARING IS KUHL” Dr. Kuhl’s recent work has focused on understanding the physical, emotional and spiritual impact on caregivers as they care for patients/residents who are dying, suffering or experiencing a crisis. His workshop will help participants learn how to: - understand how to sustain health care providers in the workplace -inspire vocational satisfaction, and revitalize compassion -explore the cost of being in the presence of suffering -strengthen relationships among care teams and practitioners -promote interdisciplinary respect - enhance psychological and spiritual well-being David is the Director of the Centre for Practitioner Renewal (CPR) and an Associate Professor for the Department of Family Practice, Faculty of Medicine at the University of British Columbia. He was the physician leader for palliative care at Providence Health Care, BC. As the Director of CPR, he is working to combine his interests in medicine and psychology to develop a program of service, education and research to sustain health care providers in the workplace. He has written two books, What Dying People Want: Practical Wisdom for the Endof-Life and Facing Death Embracing Life, Understanding What Dying People Want. Cost includes lunch: Members $60 Non members $75 Student $40 For more information please contact Debbie Springett Frymire 233-8236, [email protected] PHARMACY POINTERS Pharmacological Management of Respiratory Congestion Lindsay Lemanski BSC Pharm. Palliative Care Pharmacist At the end of life, accumulation of excessive respiratory secretions during the dying process may dominate the memory of the family for the bereavement period. The occurrence of this gurgling like sound intensifies as the patient approaches death. It arises in about 44% of patients with a Palliative Performance Scale (PPS) of 20%, and up to 52% of patients with a PPS of 10%. The mainstay of pharmacological management is the use of mucoregulatory agents, such as the anticholinergic class of medications, which inhibit upper respiratory tract secretions. These medications should be used at the first sign of congestion as they do not remove bronchial secretions already present, but do reduce additional accumulation of fluid. Traditionally, hyoscine hydrobromide is the mainstay of therapy, although glycopyrronium bromide and atropine are also being used within the WRHA Palliative Care Program. Scopolamine or hyoscine hydrobromide is a mucoreglatory agent available in several different formulations (injection, patch, gel). It is classified chemically as a tertiary amine muscarinic receptor antagonist, and is unfortunately able to pass the blood-brain barrier (BBB) and cause central nervous system (CNS) side effects such as confusion and paradoxical excitation. The BBB is a layer of cells that controls which substances may penetrate from the systemic blood circulation into the brain. However, some CNS side effects like sedation or anti-emetic activity may be advantageous near the end of life. Scopolamine has a more potent effect on bronchial secretions and would be less likely to cause tachycardia compared to atropine. In a hospital setting, the injection formulation is most commonly used for delivery of scopolamine either intravenously (IV) or subcutaneously (SUBCUT). These doses may be repeated intermittently or delivery by continuous infusion for ongoing presentation of severe respiratory secretions. Scopolamine, when used in a patch delivery system (Transderm-V® ) can be used for respiratory congestion at end of life in a preventive capacity. Being a patch formulation, it slowly releases drug over 72 hours and requires several hours to be absorbed via the skin, and build up to an effective serum level. It is thus less useful when congestion has already developed. Scopolamine gel is supplied in home kits and specially compounded by a community pharmacy. The vehicle used is pluronic lethicin organogel (PLO) which is both hydrophobic and hydrophilic in order to allow for better penetration of the skin barrier and increased absorption of the suspended scopolamine drug molecule. The onset of action is dependent on physiological and physicochemical properties of the skin and medication, but may occur within 30-60 minutes. It is an ideal agent for patients at end of life care at home when ongoing therapy is required for respiratory congestion. Glycopyrrolate or gylcopyrronium bromide is another muscarinic receptor antagonist available in an injection formulation. It is a quaternary ammonium compound and thus does not cross the blood-brain barrier, as does scopolamine. It may be useful for patients in whom the CNS effects of scopolamine such as sedation are undesirable. It has a slower onset and produces less tachycardia than either atropine or scopolamine. Subcutaneous atropine is infrequently used for respiratory secretions as generally safer alternatives are available. It has dose dependent activity on inhibiting salivation and sweating; however at higher doses produces tachycardia, urinary retention, confusion and sedation. There is only anecdotal evidence to support the use of atropine eye drops sublingually (SL) for increased salivation. Depending on availability of routes and/or concurrent medications, atropine eye drops sublingually can be considered as an alternative. A recent prospective study demonstrated no significant difference between the effectiveness of subcutaneously administered scopolamine or atropine on respiratory secretions and patient congestion. A number of considerations guide the management of respiratory congestion at end of life, such as medication availability, physician preference, route availability and desired level of consciousness. Treatment with two or more mucoregulatory agents will unfortunately only increase undesirable side effects, and thus cannot be recommended. Comparison of Common Anti-cholinergic Drugs for Respiratory Congestion Drug Effect Dryness Atropine Yes Glycopyrrolate High Crosses BBB/ Type of amine CNS: excitation, delirium, hallucinations Route approved Yes Tertiary Only at toxic doses No Quaternary None SUBCUT, IV, IM SL PO, SUBCUT, IV TD, SUBCUT, IV, IM (Eye drops)SL: 1-2 drops Q12H PRN SUBCUT: 0.2-0.4 mg Q1H PRN SUBCUT 0.3-0.6mg Q1H PRN TD: 1mg/72 hours Gel 0.25mg/mL: 0.10.2 ml Q4-6H PRN Route non-label use Common dosage at St. Boniface General Hospital Scopolamine 8-9X higher than atropine Yes Tertiary Can occur in toxic doses TD= Transdermal References: Downing, GN et al. Medical Care for the Dying, 4th edition. 2006: 381-89. Wildiers, H et al. Atropine, Hyoscine Butylbromide, or scopolamine are equally effective for the treatment of death rattle in terminal care. J Pain Symptom Management 2009; 38(1): 124-133. Wildiers, H et al. Treatment of death rattle in dying patients. Belgian Journal of Medical Oncology 2008; 2(5): 275- RESEARCH NEWS Research Study: Exploring Ethical Practice in Palliative Home Care Using Appreciative Inquiry We are carrying out a study to explore and describe ethical practice in palliative home care from the perspective of patients, their family members, palliative home care team members, and other key stakeholders. This study is funded by the Canadian Institutes of Health Research. We would like to interview approximately 15 palliative home care team members. If you have worked with the Palliative Home Care Team for a minimum of one year you are eligible to participate. Participation is voluntary and involves a maximum of two face-toface individual interviews with a research team member, each lasting from 45 to 60 minutes. These interviews will take place at a mutually convenient time and place and will be audio-recorded. You will be asked some demographic questions, and about your sense of the ideal relationship with patients and family members and the types of ethical issues you encounter in your practice. You will also be asked to tell a story of getting it right when responding to an ethical issue or concern. You may refuse to answer any questions posed and may withdraw from the study at any time. A $10.00 gift certificate for a coffee shop will be provided to all participants. Confidentiality will be safeguarded, and all data will be stored in a locked cabinet or password-protected computer. Only members of the research team will have access to the data. Pseudonyms will be used and no identifying information will appear in any presentation or publication arising from the study. If you are interested in learning more about this study, please contact: Research Nurse – Laurie Read – 474-9633 OR Marie Edwards – 474-8218 This study has been approved by the University of Manitoba Education and Nursing Research Ethics Board. Thank you for considering our request. If you have any questions or concerns about this project, you may contact the Human Ethics Coordinator at 4747122 or [email protected]. Marie Edwards, RN, PhD Co-Principal Investigator [email protected] [email protected] Susan McClement, RN, PhD Co-Principal Investigator COLLEAGUE COMMUNICATIONS Hi my name is Barb and I’m a Palliative coordinator in rural Manitoba, sharing one half of a Regional Health Authority. I’ve been in this role since October 2008. Before I came to this position, I spent 13 years with Home Care as a direct service nurse, case coordinator and hospital discharge planner. All of these roles have helped me grow, stretch, push and pull me to a new understanding and passion for palliative care and what it means to care for those individuals who face the challenges of a life ending illness. Our palliative care program is available in the home, and at all health centers and personal care homes in the region. So what does that mean for me? Well, I visit as many of the communities as I can at least once a month. There are 12 facilities; 6 of which are acute care with a PCH attached and the rest solely PCHs with anywhere from 8 – 102 residents. The 6 acute care facilities have 10 –35 beds. This does not include all the small villages and hamlets that are in the area, but do not have medical facilities. Today I am working on an in-service session for staff at all the facilities under my umbrella on grief and bereavement. Education is a big part of my job, teaching staff, clients, families and general community contacts what Palliative Care is all about. It’s been a challenge to get to know the doctors, nurses, and staff on each community’s interdisciplinary teams as they provide palliative care in each area and facility. Each community/facility has the common goal of caring for the palliative client and families, each community as diverse as the individuals they care for. Most of the communities have Palliative Care Committees (consisting of health care providers and volunteers), whose role is to enhance awareness and delivery of quality care for palliative care clients and families. I do work with clients directly in some cases where there are symptom control issues or other issues that staff need assistance with. These types of direct client visits mostly occur in homes in rural areas and require some sort of teaching or education for direct service staff, clients and families. The volunteer program complements the professional health care team in providing practical, social, emotional and spiritual support. Most of the facility visits provided by the palliative program are arranged through our volunteer programs. I receive the referral initially and then forward it on to the volunteer coordinator. I try to attend all the community volunteer meetings to assist them with their projects and answer their questions. Each community group is expected to meet four times per year. I act in an advisory role with the volunteers. I also arrange the Hospice & Palliative Care Manitoba volunteer course in the rural areas. Camp Bridges is a project that is held every year for children ages 7 – 17 who have suffered the death of someone close to them. Getting organized for the camp mail outs for this year’s camp has started and there is a day for training the volunteers. The geographical region that I cover is 220 km from north to south and 121 km from east to west. A reliable car is a necessity. Don’t forget the survival gear, and get used to having lunch, coffee, etc while you drive! At this moment as I write this for the MPCNA, I have 62 open active palliative clients, spread out through the 12 facilities and home care. The needs of these clients range from volunteer respite for a few hours to daily nursing visits for complex dressing changes and symptom monitoring/management. Some days can be very tiring, but the sense that I’ve assisted someone at the end of life’s journey is a great joy and makes it all worthwhile. A wife who has been caring for her husband at home (as he wished) calls me to tell me he died last night peacefully, his children around him, on the sofa with his head in her lap. She is grateful, stating it was difficult but it was also very rewarding and thanks me for making it possible. The daughter in Vancouver who wanted to be with mom at the end, but just couldn’t get there in time, but a volunteer was, thank you, mom was not alone. This is what Palliative Care is about and why I continue to do the work I love. Submitted by Barb Packwood, Regional Palliative Care Coordinator, Assiniboine Regional Health Authority MPCNA MEMBERSHIP INFORMATION Annual dues are $15 In addition to the networking opportunities, educational sessions, and support, a membership to MPCNA also provides: 1) A discount on the Annual Spring Workshop in May. This workshop is always well attended and participants agree that the speakers provide informative and relevant lectures for those working in palliative care. 2) One draw ticket for one of 4 one-day entrances to the Hospice and Palliative care conference. This year the conference will join with the National Conference of Palliative Care here in Winnipeg. 3) One draw ticket for the Annual Spring Workshop. Memberships can be paid at any MPCNA event or by sending a cheque with contact information to the Association Treasurer, Donna Grassie, MPCNA, PO. Box 2545, Winnipeg, Manitoba, R3C 4B3. For more information contact Donna Grassie at [email protected]. The association’s preferred method of correspondence is by email. If you have not received earlier notices by email and you do have one, please send email contact info to [email protected]. Snail mail notices will be sent out only upon request. NEWSLETTER CONTACTS If you would like to include any notices of upcoming events, submissions of stories, books you would like others to know about, or any suggestions for future editions, please send the information to one of the following email addresses: [email protected] or [email protected],